Back to top
more

resTORbio, Inc. (TORC)

(Delayed Data from NSDQ)

$8.16 USD

8.16
76,131

+0.08 (0.99%)

Updated May 3, 2019 04:00 PM ET

After-Market: $8.10 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Adicet Bio, Inc. [TORC]

Reports for Purchase

Showing records 1 - 20 ( 28 total )

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 1

03/16/2020

Company Report

Pages: 6

Q4 Financials; PD Study Continues As TORC Explores Strategic Alternatives

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 2

11/15/2019

Company Report

Pages: 7

Downgrading to NEUTRAL on PROTECTOR Fail; Focus Shifts to Parkinson?s

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 3

11/05/2019

Company Report

Pages: 8

Q3 Financials; PROTECTOR 1 Topline Data Around the Corner

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 4

10/08/2019

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for TORC

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 5

09/27/2019

Daily Note

Pages: 10

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 6

08/20/2019

Daily Note

Pages: 6

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 7

08/19/2019

Company Report

Pages: 7

Q2 Financials, PROTECTOR 1 Study Topline Data Ahead in Early Q1:20

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 8

07/24/2019

Daily Note

Pages: 14

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 9

07/24/2019

Daily Note

Pages: 5

First Phase 3 Enrollment Complete; Data in Early Q1:2020

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 10.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 10

05/20/2019

Company Report

Pages: 7

Q1 Financials; RTB101: PROTECTOR of the Realm?

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 11

05/20/2019

Company Report

Pages: 7

Q1 Financials; RTB101: PROTECTOR of the Realm?

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 12

03/25/2019

Company Report

Pages: 6

Q4 Financials; Financing Supports Clinical Progress

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 13

03/18/2019

Company Report

Pages: 7

Ph 3 Designs Announced; On Track for Q2:19 Initiation

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 14

02/07/2019

Daily Note

Pages: 5

Compelling Rationale for TORC1 Inhibition in Parkinson?s Disease

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 10.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 15

02/01/2019

Industry Report

Pages: 8

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 16

11/13/2018

Company Report

Pages: 6

Q3 Financials; Studies on Track to Initiate in 1H:19

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 17

10/16/2018

Company Report

Pages: 5

Additional Ph 2b Data Analyses Support Immune Function Benefit of RTB101

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 10.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Unclassified

Record: 18

08/24/2018

Daily Note

Pages: 7

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Unclassified

Record: 19

08/23/2018

Company Report

Pages: 6

Q2 Financials; Ph 3 On Track for 1Q19

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party

Company: Adicet Bio, Inc.

Industry: Unclassified

Record: 20

07/25/2018

Company Report

Pages: 8

Top-line Ph 2b Data Positive; Clear Path Forward for Ph 3 Program

Provider: WEDBUSH SECURITIES INC.

Analyst: DRISCOLL R

Price: 25.00

Research Provided by a Third Party
// eof